BDSX Biodesix, Inc.
Healthcare$14.81-0.80%ClosedMarket Cap: $120.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
15.79
P/S
1.26
EV/EBITDA
-9.14
DCF Value
$-279.99
FCF Yield
-20.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.1%
Operating Margin
-25.9%
Net Margin
-33.3%
ROE
-2101.4%
ROA
-33.8%
ROIC
-30.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $25.6M | 83.5% | $-6.2M | $-7.8M | $— | — |
| Q4 null | $28.8M | 83.0% | $-2.0M | $-4.0M | $— | — |
| FY null | $88.5M | 81.1% | $-27.8M | $-35.3M | $— | — |
| Q3 null | $21.8M | 81.1% | $-7.0M | $-8.7M | $— | — |
| Q2 null | $20.0M | 79.9% | $-9.7M | $-11.5M | $— | — |
| Q1 null | $18.0M | 79.4% | $-9.1M | $-11.1M | $— | — |
| Q4 null | $20.4M | 78.7% | $-6.6M | $-8.3M | $— | — |
| FY null | $71.3M | 78.2% | $-34.5M | $-42.9M | $— | — |
| Q3 null | $18.2M | 77.0% | $-8.6M | $-10.3M | $— | — |
| Q2 null | $17.9M | 78.4% | $-8.2M | $-10.8M | $— | — |
| Q1 null | $14.8M | 78.6% | $-11.0M | $-13.6M | $— | — |
| Q4 2023 | $14.7M | 77.0% | $-6.8M | $-9.1M | $-1.98 | — |